FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction – FDA.gov

https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-virtual-reality-system-chronic-pain-reduction FDA NEWS RELEASE FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction  For Immediate Release:November 16, 2021 EspaƱol The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with pain reduction in patientsContinue reading “FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction – FDA.gov”